Respiratory syncytial virus (RSV) is one of the most common etiological agents of childhood respiratory infections globally. Information on seasonality of different antigenic groups is scarce. We aimed to describe the frequency, seasonality, and age of children infected by RSV antigenic groups A (RSVA) and B (RSVB) among children with ARI in a 4-year period.
Introduction
Acute respiratory infections (ARI) are the leading cause of mortality in children less than 5 years old worldwide. [1] Viruses are major contributors to the morbidity and mortality of ARI, and respiratory syncytial virus (RSV) is one of the most common etiological agents of respiratory infections such as bronchiolitis and pneumonia. [2, 3] It is estimated that nearly all children have been infected by RSV by their second birthday. [4] Surveillance to track RSV circulation is essential to establish effective preventive measures to control RSV-associated severe ARI episodes. [5] RSV incidence can be highly variable within countries and between regions within a country depending on the level of seasonal constraining. [6] Temperature, rainfall, and humidity have been postulated to significantly impact RSV seasonality [7] and information on seasonality of different antigenic groups is scarce.
In this study, we aimed to describe the frequency, seasonality, and age of children infected by RSV antigenic groups A (RSVA) and B (RSVB) among children with ARI in a 4-year period.
Methods

Study design
This prospective cross-sectional study evaluated children with ARI seen at the Pediatric Emergency Department of the Federal University of Bahia Hospital, in Salvador, Northeastern Brazil, between September, 2009 and October, 2013. This city is located in a tropical region, the latitude being 12°5801600S, the longitude 38°3003900W, and the altitude 8 m. Inclusion criteria comprised children aged from 6 to 23 months with fever, sneeze, running nose, nasal blockage, or cough for up to 7 days. Children transferred from other hospitals or reporting a previous episode of wheeze were excluded. Clinical and demographic data, as well as findings on physical examination, were collected using a standardized questionnaire.
Clinical definitions
Fever was defined as axillary temperature >37.4°C, [8] and tachypnea as respiratory rate (RR) ≥50 breaths/min among children aged 6 to 11 months and RR ≥40 breaths/min in children from 12 months of age upwards. [9] Lower respiratory tract infection (LRTI) was considered when the child had tachypnea and/or any respiratory distress or crackles or wheezing. [10] Age strata were defined as: under 1 year when children were 364 days old, and 1 year and above when children were ≥365 days old.
Laboratory procedures
Nasopharyngeal aspirate (NPA) samples were collected at study enrollment, placed in Nuclisens Lysis Buffer (Biomeriux, Boxtel, The Netherlands) and frozen at À70°C. Total ribonucleic acid was extracted using RNEasy (Qiagen's, Hilden, Germany) following manufacturer's instructions. A multiplex quantitative RT-PCR with a group-specific primer and probeset for RSVA and RSVB was used to identify the different antigenic groups of the virus. [11] The carboxyterminal region of the G protein was amplified using the One-Step RT-PCR (Qiagen, Westburg, The Netherlands). The RSVA forward and reverse primers, G267FW and F164RV, respectively, and the RSVB forward and reverse primers, BGF and BGR, respectively, were employed. [11] 2.4. Meteorological data Data about rainfall, relative humidity, air temperature, and hours of sunshine were provided by the Institute of Environment and Water Resources (INMET) in the State of Bahia with no missing data over the months studied. The meteorological station that provided the data is located approximately 2 km away from the Emergency Department where the study was carried out. Rainfall was measured as daily precipitation, in millimeters, and was analyzed as the total quantity of the month. Relative humidity (%) and air temperature (°C) were measured three times per day, and these were averaged monthly. Hours of sunshine were measured as daily duration of sunshine, in hours, and were calculated as monthly totals.
Statistical analysis
Sample size was estimated on an expected frequency of RSV infection of 30%, total width of confidence interval equal to 0.10, and 99% confidence level. Thus, the sample size was estimated at 558 cases. Categorical variables were presented as absolute numbers (percentage) and continuous variables as the median (interquartile range [IQR] ). 95% Confidence Interval (95% CI) was calculated for the outcome variables. Categorical variables were compared using the corrected chi-square or Fisher's exact test, as appropriate. The seasons and their corresponding months were: summer (January, February, March), fall (April, May, June), winter (July, August, September), and spring (October, November, December). Time series analysis using Prais-Winsten generalized linear regression (Y(i) = b0 + b1 * X(i) + b2 * sin[2pX(i)/ 12] + b3 * cos[2pX(i)/12]-in which "Y(i)" is the time series measure for each moment "i"; "b0" is a constant; "b1" is the trend indicator; "b2" and "b3" are seasonality indicators) was used for seasonality detection of logarithmic transformed monthly RSVA or RSVB number of cases. This regression model detects monthly fluctuations in the number of cases that are consistent between years when the coefficient "b2" or "b3" is statistically different from zero. The association between logarithmically transformed monthly RSVA or RSVB number of cases with monthly values of meteorological factors was evaluated by multiple regression using Prais-Winsten generalized linear regression. Statistical tests were two-tailed, with a significance level of 0.05. The software Stata version 12 (StataCorp, USA) was used for these analyses.
Ethical approval
The study was approved by the Ethics Committee at the Federal University of Bahia. Parents or legal guardians signed written informed consent forms before enrollment of each study participant. 10.6%-16.2%) cases, and RSVB in 67 (12.0%; 95% CI: 9.5%-14.9%) cases. Two (0.4%; 95% CI: 0.06%-1.2%) were coinfected. Table 1 shows the distribution of RSVA or B cases per year of study. RSVA occurred more frequently in 2011 and 2012 whereas RSVB occurred more often in 2010 and 2013. RSVB frequency demonstrated seasonal distribution (b2 = À0.44 and b3 = À0.24; P = 0.01) and was more frequent (P < 0.001) in March to June (36.0%) compared with July to October (1.0%) or November to February (1.6%). Conversely, RSVA was more frequent from August to January compared with February to July (18.2% vs. 6.4%, P < 0.001). RSVA cases were distributed in several distinct months in different years. The RSVA seasonal pattern was not statistically significant on a monthly basis. Table 2 shows the monthly distribution of RSVA and RSVB during the study period. It is possible to verify that there was an alternating pattern between RSVA and RSVB cases.
There was a positive association between monthly RSVB number of cases and humidity (multiple regression coefficient for humidity = 0.10; P = 0.02). There was no association between RSVA frequency and meteorological factors. Figure 1 shows the monthly distribution of mean relative humidity and of RSVA and RSVB number of cases during the study period. All meteorological factors showed seasonal distribution (Fig. 2) . Table 3 shows that RSVA was more frequent among children aged 1 year and above compared with younger children (17.8% vs. 10.8%; P = 0.02). No difference was found in the distribution of RSVB in regard to age strata (11.5% vs. 12.2%; P = 0.8). RSVA was similarly found among patients with or without their lower respiratory tract being compromised (12.6% vs. 13.6%; P = 0.7). Likewise, RSVB was similarly distributed among these subgroups (12.2% vs. 11.8%; P = 0.9). Table 4 compares the frequency of symptoms, signs, and day care center attendance between cases with or without RSV detected. No difference was found. 
Discussion
RSVB infection showed seasonal distribution with higher frequency in late summer and fall and had positive correlation with humidity. In contrast, RSVA infection did not show a consistent seasonal pattern throughout the 4 years study. That is, RSVA and RSVB infection occurred in different months in this tropical city. To the best of our knowledge, this study is the first to demonstrate that infection by the different antigenic groups RSVA or RSVB occurs in different months during the year. Our study has limitations. It was conducted in a single center. Similar studies enrolling children at multiple centers throughout the full 12 calendar months and for at least 4 years are necessary in order to reach definitive conclusions about the different seasonal characteristics of RSVA and RSVB. Moreover, genotype data on the different circulating subtypes are not available. Additionally, children aged under 6 months were not included. However, the option to study children aged ≥6 months was due to the fact that these children usually go out and are in contact with people living in the community. Breastfeeding is very frequent in our country during the first 6 months of life as maternity leave lasts for 6 months after delivery. Therefore, children aged <6 months are less exposed than those aged ≥6 months.
RSV infection distribution has been recently addressed between April 2012 and March 2013 among children younger than 2 years hospitalized with LRTI in 4 cities in Northeastern Brazil; however, the infection distribution of the different antigenic groups A and B was not assessed. [12] It has been shown that the activity of RSVA and B usually occurs in association with the rainy season and there is evidence that temperature and associated factors, primarily humidity, are important factors in the seasonality. [7] These factors can influence the fusion of viruses with the cellular membranes allowing for cell entry and replication. Humidity strongly influences virus stability and transmissibility. [13] Herein, infection by RSVB was positively associated with humidity. Different studies conducted in Belgium, Finland, Pakistan, the UK, and Uruguay have presented the cocirculation of RSVA and B in the same period of the year. [11, [14] [15] [16] However, in our study, which lasted 4 years and was conducted in the tropical city of Salvador, Brazil, the monthly circulation of RSVA and B was markedly different. There were different periods of high humidity during the 4 years studied (Fig. 1) . Herein, RSVA and B circulated not only in different months but also in different years with alternating yearly patterns ( Table 1) . That is why RSVA and RSVB coinfection rate was very low (0.4%). The pattern of 2 to 4 consecutive years of group A predominance followed by a single intervening year in which group B is dominant was reported in countries like Uruguay and Finland. [14, 15] Competitive relationship and crossimmunity between these antigenic groups have been reported in the population. Following infection, individuals gain transient immunity which average duration is 2 years. [15] Among our cases, overall, RSV was found in 24.8%. A study conducted in Southeastern Brazil reported that 27.4% of children aged less than 2 years with ARI had RSV. [2] Other studies conducted in the Northern and Southeastern Brazil presented similar frequencies in children aged less than 2 to 3 years with ARI. [17, 18] One study carried out in another city in Northeastern Brazil showed that 48% of the children had RSV. This finding may be attributed to the study period, as the study was carried out only in the rainy season. [19] It has been shown that RSV frequencies depend on local climate and can vary between 27.8% and 37.9% in temperate, subtropical, and tropical countries, in the same age population. [6, [20] [21] [22] [23] We showed that there was no difference between the overall RSV groups frequency (13.2% vs.12.0%). However, RSVA is usually predominant in the majority of the studies involving children with ARI. [12, 14, 20, 24] RSVA predominance has been attributed to the higher variability among these group strains and normally the dominant strain has a mechanism for frequent reinfections by evasion of immunity induced by previous strains. [25] This absence of RSVA predominance in our study may be explained by the unique total length of Medicine the study (4 years), of which 2 years were dominated by RSVA and 2 years were dominated by RSVB. We found that RSVA was more common among children aged 1 year and above. A study conducted in 7 different countries presented that, across all countries, RSVA was more frequent in children aged 36 to 59 months whereas the lowest frequency was detected in the 6 to 11 months old group. In that study, children between 6 months and 10 years of age were included. [26] In general, it has been described that RSV is frequent in children under 1 year of age. However, the distribution of different antigenic groups (A and B) is not commonly reported.
Almost half of the children presented lower respiratory tract involvement (41.1%) and the frequency of RSVA and B was not different among children with or without such involvement. It has been reported that children with RSV infection present frequent involvement of the lower respiratory tract. [27, 28] Our samples were collected from children in the emergency department irrespective of severity. Moreover, the etiological diagnoses were performed with very sensitive methods. That is, this study included primarily children with ARI (not only LRTI) and RSV was searched for by very sensitive tests. This strategy allowed us to detect RSV among children with ARI, without predefined The monthly and yearly distribution of infection by RSV is usually addressed during fall and winter months, all over the world. As such, the distribution of the cases infected by RSV is known to occur during the RSV season. Based on these findings, recommendations for immunoprophylaxis for high risk groups of severe disease have been made as the RSV distribution along the year impacts on the immunoprophylaxis calendar with monoclonal antibody. In Brazil, palivizumab applications are recommended between February and July in the Northeastern region. [29] This practice is based on the assumption that RSV circulates between March and July in these regions. This routine is influenced by guidelines developed and implemented in countries in temperate regions. [30] However, we demonstrated that RSV infection occurs not only during the expected RSV season. Indeed, RSVB infection occurs during the RSV season but this is not the case for RSVA. Taking into account that our results were provided in a 4-year period of data collection, guidelines for specific immunoprophylaxis against RSV should be reviewed in the tropical region. In the current form, prophylaxis is appropriate for infection by RSVB but not for infection by RSVA. Furthermore, our findings highlight the necessity to implement RSV vaccine, which should be effective against both antigenic groups A and B, as vaccination confers protection for longer periods of time than the current available passive immunization (palivizumab). Further studies conducted in tropical regions with data collection during the whole year calendar for at least 4 years would be highly appreciated. The duration of our study was fundamental in order to find our results.
Conclusion
We conclude that seasonality was markedly different between distinct antigenic groups, when RSVA presented a non-seasonal pattern. A positive association between RSVB and humidity was found. One quarter of the patients had RSV detected, similar to other studies in the same region. RSVA compromised more frequently children aged 1 year and above. Guidelines for specific immunoprophyl axis against RSV should be reviewed in the tropical region as the circulation of RSV is supposedly at the same time among otherwise healthy children as among high risk groups of severe RSV infection. Results presented as absolute number (percentage). RSVA = respiratory syncytial virus antigenic group A, RSVB = respiratory syncytial virus antigenic group B.
Table 4
Comparison of the frequency of symptoms, signs, and day care center attendance between children with acute respiratory infection with or without respiratory syncytial virus detected in nasopharyngeal aspirates.
Characteristics
Respiratory syncytial virus P Yes (n = 139) No (n = 421) 
